Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
Aliment Pharmacol Ther ; 42(10): 1192-9, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26354674

RESUMO

BACKGROUND: Optimising infliximab therapy is recommended in inflammatory bowel disease (IBD) patients who lose response to infliximab; however, there are no data on the outcome of ulcerative colitis (UC) patients after doubling the dose. AIM: To determine the efficacy and safety of infliximab dose doubling in UC patients with a loss of response to infliximab. METHODS: From January 2006 to May 2013, we retrospectively reviewed the outcome of the consecutive UC patients who were treated with infliximab dose doubling (10 mg/kg) for loss of response in four French academic centres. The clinical response and remission were assessed. A composite event-free survival analysis was performed using the log-rank test and the Cox model. RESULTS: One hundred and fifty-seven patients [84 males; median age 37. 6 (IQR 28.2-49.4) years] were included. The median follow-up after infliximab dose doubling was 1.8 (1.0-3.1) years. At weeks 8 and 24, 55% and 43% of the patients achieved a clinical response respectively. The probabilities of the event-free survival were 71%, 61% and 55% at 6 months, 1 year and 2 years respectively. In the multivariate analysis, the predictors of infliximab dose doubling failure were the absence of the introduction of an immunomodulator concomitantly to dose doubling, a partial Ulcerative Colitis Disease Activity Index >6, a C-reactive protein level >10 mg/L, a leucocyte count >8000/mm(3) and a haemoglobin level <12.5 g/dL. Adverse events were reported in 12 patients (8%). CONCLUSIONS: Infliximab dose doubling led to short- and long-term event-free survival in UC patients, who had a loss of response to infliximab, in greater than 50% of the cases. The benefits of such a strategy were significantly improved by adding a concomitant immunomodulator.


Assuntos
Colite Ulcerativa/tratamento farmacológico , Fatores Imunológicos/administração & dosagem , Infliximab/administração & dosagem , Adulto , Proteína C-Reativa/metabolismo , Intervalo Livre de Doença , Feminino , Humanos , Fatores Imunológicos/uso terapêutico , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Estudos Retrospectivos , Resultado do Tratamento
3.
Rom J Morphol Embryol ; 43(3-4): 205-12, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9747122

RESUMO

The "Histological Typing of Odontogenic Tumours" (W.H.O., 1992) classified the Calcifying Odontogenic Cyst (C.O.C.) into two variants: the non-neoplastic cystic C.O.C. and the odontogenic ghost cell tumour, which is predominantly solid. We reported two cases of C.O.C.: a case with intraosseous development and another with extraosseous localisation, in the soft tissue of the alveolar area. The first case represents a cyst delimited by a squamous, non-keratinized epithelium, thickened in some areas through the accumulation of ghost cells (big pale-staining cells with a non-staining nuclear area). The connective tissue wall contains small ameloblastoma like islands. Dysplastic dentine islands, adjacente to the basal layer of the epithelium or in the connective tissue wall were also observed. The second case was a well-delimitated tumour consisting of ameloblastoma-like islands with numerous ghost cells inside. Islands of dysplastic dentine with psammomathous calcifications also exist. In certain histological sections microcystic aspects surrounded by ghost cells, dentinoid and ameloblastoma-like structures were noticed. The histochemical reaction for keratin and the immunohistochemical reaction for epithelial membrane antigen and for citokeratin were positive for ghost cells, suggesting their epithelial origin. Through this article we try to render pathologists sensitive with a particular and rare maxillary tumour.


Assuntos
Neoplasias Maxilomandibulares/patologia , Neoplasias Maxilares/patologia , Cisto Odontogênico Calcificante/patologia , Adolescente , Idoso , Processo Alveolar , Biomarcadores/análise , Feminino , Humanos , Neoplasias Maxilomandibulares/cirurgia , Queratinas/análise , Neoplasias Maxilares/cirurgia , Mucina-1/análise , Cisto Odontogênico Calcificante/diagnóstico por imagem , Cisto Odontogênico Calcificante/cirurgia , Radiografia
4.
J Med Life ; 6(3): 310-5, 2013 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-24146693

RESUMO

RATIONALE: Cardiac risk in patients undergoing surgery depends on many factors from the patient's cardiovascular history to the surgical procedure itself, with its particularities, the type of anesthesia, fluid exchanges and the supervision of the patient. Therefore, this risk must be carefully considered and it determines the endorsement of perioperative measures with important medical implications. OBJECTIVE: Perioperative cardiac risk evaluation guidelines were published since 2010 and they represent a highly important assessmnet tool. Emergency surgery requires an adaptation of the guidelines to the actual medical situations in extreme conditions. METHODS, RESULTS, DISCUSSION: Analyzing the way the perioperative evaluation itself is conducted is an extremely important tool. Quantifying the clinical application of the guidelines, one can monitor real parameters and find solutions for improving medical care. The current study was conducted on a representative sample of 8326 patients, respecting the recommendation strategies for calculating the surgical risk adapted for the emergency surgery setting. The dominant conclusion is the need to develop a standardized form, summarized for quick and objective assessment of perioperative cardiac risk score. Only a complex medical team could calculate this score while the decisional team leader for the surgical patient remains the surgeon.


Assuntos
Procedimentos Cirúrgicos Cardiovasculares/efeitos adversos , Serviços Médicos de Emergência , Assistência Perioperatória , Guias de Prática Clínica como Assunto , Biomarcadores/metabolismo , Eletrocardiografia , Testes de Função Cardíaca , Hemodinâmica , Humanos , Fatores de Risco
6.
Rev Med Chir Soc Med Nat Iasi ; 99(3-4): 211-4, 1995.
Artigo em Romano | MEDLINE | ID: mdl-9455369

RESUMO

The authors discussed the effects of nuclear accident from Chernobyl (1986) upon the histotypes of cerebral glial tumors, first diagnosed during 1981-1991 at the Department of Pathology, Neurosurgical Hospital, Iasi. It's microscopic diagnosis was determined according to the World Health Organization criterion (1979). The investigations established a tendency to diminish the incidence of astrocytomas and to increase the oligo-astrocytic tumors number, after 1986. Malignant astrocytomas did not presented any modifications with statistical significance during the eleven studied years.


Assuntos
Neoplasias Encefálicas/epidemiologia , Exposição Ambiental/efeitos adversos , Glioma/epidemiologia , Neoplasias Induzidas por Radiação/epidemiologia , Liberação Nociva de Radioativos , Exposição Ambiental/estatística & dados numéricos , Humanos , Incidência , Moldávia/epidemiologia , Morbidade/tendências , Centrais Elétricas , Liberação Nociva de Radioativos/estatística & dados numéricos , Ucrânia
7.
Virologie ; 36(4): 269-72, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-3004017

RESUMO

The NIVGRIP inactivated influenza vaccine was administered by oral route to 11 children of a semi-closed pre-school community, found to carry viruses in their nasopharynx. Periodic virological investigations demonstrated that after vaccination virus carriage disappeared completely in 7 children; in the remaining 4 cases there was a considerable decrease (from 14 to 6) in the number of virus strains isolated. The virus isolates obtained after vaccination were represented exclusively by enteroviruses (Coxsackie B1 and B3, poliovirus type 1), in contrast with the wider range of viral agents (adeno-, parainfluenza, herpes, Coxsackie, and polioviruses) detected prior to vaccine administration.


Assuntos
Portador Sadio/microbiologia , Vacinas contra Influenza/administração & dosagem , Influenza Humana/microbiologia , Nasofaringe/microbiologia , Administração Oral , Portador Sadio/prevenção & controle , Pré-Escolar , Enterovirus/isolamento & purificação , Humanos , Lactente , Recém-Nascido , Vírus da Influenza A/isolamento & purificação , Vírus da Influenza B/isolamento & purificação , Influenza Humana/prevenção & controle , Vacinas Atenuadas/administração & dosagem
8.
Endocrinologie ; 23(3): 205-11, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4048820

RESUMO

A 26-year-old woman was admitted to the Institute of Endocrinology in Bucharest for evaluation of primary hyperparathyroidism (P-HPT). Anamnesis revealed a 10-year history of nephrolithiasis; peptic ulcer, chronic pancreatitis, cholelithiasis. Eight months previously, she had given birth to a child who had neonatal hypocalcaemic tetany. Investigations revealed the presence of moderate hypercalcaemia, hypercalciuria, hypo-phosphoremia; serum chloride level was above 100 mEq/1, and the chloride phosphate ratio was greater than 33. X-ray films of the abdomen revealed the presence of nephrolithiasis and right nephrocalcinosis. Selenium methyonine scanning, ultrasonography and computerized tomography were negative. On surgical exploration a 2-3 cm parathyroid adenoma was removed from between the trachea and the esophagus.


Assuntos
Doenças Ósseas/patologia , Hiperparatireoidismo/patologia , Adulto , Cálcio/metabolismo , Feminino , Humanos , Hiperparatireoidismo/diagnóstico , Hiperparatireoidismo/metabolismo , Fósforo/metabolismo
9.
Rev Med Chir Soc Med Nat Iasi ; 102(3-4): 145-9, 1998.
Artigo em Romano | MEDLINE | ID: mdl-10756864

RESUMO

PURPOSE: This paper is a study concerning the clinical-imagistic correlations in lacunar infarcts causes and associated lesions in these ones. We made an attempt to find out and emphasize the risk factors, causes and pathogenic mechanisms involved in lacunar syndromes. MATERIALS AND METHODS: We studied 138 patients with lacunar infarcts diagnosed by clinical examination and computer tomography. The investigation of risk factors evidenced arterial hypertension in 75 cases (54%). The clinical features of lacunar syndromes were: 1) pure motor stroke 41c; 2) pure sensory stroke 8c; 3) ataxic hemiparesis 9c; 4) dysarthria-clumsy hand 1c; 5) sensorimotor stroke 21c; 6) Landry syndrome 1c. RESULTS: We correlated the clinical manifestations and complementary investigations what enabled us to charge in determining of lacunar infarcts: focal microangiopathy-small artery disease (75c), cardio-embolic mechanism (12c), arterio-arteriolar embolic mechanism (15c). The risk factors and pathogenic mechanisms need more adequate research in order to find appropriate prevention and medical attendance.


Assuntos
Infarto Cerebral/diagnóstico por imagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Encéfalo/diagnóstico por imagem , Artérias Carótidas/diagnóstico por imagem , Infarto Cerebral/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Tomografia Computadorizada por Raios X , Ultrassonografia
10.
Rev Med Chir Soc Med Nat Iasi ; 104(2): 143-9, 2000.
Artigo em Romano | MEDLINE | ID: mdl-12089980

RESUMO

The risk to developing a neoplasm is increased when associated to a patient phakomatosis (Recklinghausen neurofibromatosis, Bourneville's tuberous sclerosis). We analysed 6 cases with phakomatosis and tumours, admitted in the Department of Oncopediatry, between 1993-1998; five of these children had neurofibromatosis and one Bourneville's disease. The associated tumours were hematologic malignancies (juvenile myeloid chronic leukemia) and solid tumors (rhabdomyosarcoma, hepatic carcinoma, CNS tumour, NHL optic glioma). The diagnosis was confirmed by microscopic examination of the bioptic material in all cases. Tumoral staging was performed by clinics, biology and imagistic investigations. All cases had extensive and aggressive tumours at the moment of diagnosis, We noticed a poor response and an early relapse after chemotherapy. A special follow-up and a different management has to be established for the patients with phakomatosis, in order to have a good oncological prophylaxis.


Assuntos
Leucemia Mielogênica Crônica BCR-ABL Positiva/complicações , Neurofibromatose 1/complicações , Neoplasias Orbitárias/complicações , Rabdomiossarcoma/complicações , Esclerose Tuberosa/complicações , Adolescente , Criança , Pré-Escolar , Evolução Fatal , Feminino , Seguimentos , Humanos , Leucemia Mielogênica Crônica BCR-ABL Positiva/diagnóstico , Leucemia Mielogênica Crônica BCR-ABL Positiva/terapia , Masculino , Estadiamento de Neoplasias , Neurofibromatose 1/diagnóstico , Neurofibromatose 1/terapia , Neoplasias Orbitárias/diagnóstico , Neoplasias Orbitárias/terapia , Rabdomiossarcoma/diagnóstico , Rabdomiossarcoma/terapia , Esclerose Tuberosa/diagnóstico , Esclerose Tuberosa/terapia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa